Related Experiment Video
Updated: Aug 29, 2026

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
Androgen suppresses PML protein expression in prostate cancer CWR22R cells
Lin Yang1, Shauh-Der Yeh, Shaozhen Xie
1George Whipple Lab for Cancer Research, Department of Pathology, The Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA.
Abstract:
The ability of PML to modulate key suppressive pathways in tumor cells suggests that PML may act as a tumor suppressor. The detailed mechanism of how PML functions in prostate cancer progression, however, remains unknown. Here we demonstrate that in the presence of androgen, PML protein expression can be suppressed in CWR22R prostate cancer cells. Further studies reveal that PML can selectively suppress AR transactivation and PML protein expression positively correlates with increased p21 protein level and enhances p53 transcription ability in CWR22R cells. We also found that PML strongly inhibits CWR22R cell colony formation, while PML siRNA enhances AR activity and CWR22R cell colony formation. Together our results suggest that PML may suppress prostate cancer cell growth by inhibiting AR transactivation and/or enhancing p53 activity.
Insights
Promyelocytic leukemia (PML) protein acts as a tumor suppressor in prostate cancer by inhibiting androgen receptor (AR) transactivation and enhancing p53 activity, thereby suppressing tumor cell growth.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Promyelocytic leukemia (PML) protein's role in modulating tumor suppressive pathways suggests its potential as a tumor suppressor.
- The specific mechanisms of PML in prostate cancer progression are not fully understood.
Purpose of the Study:
- To investigate the functional mechanism of PML in prostate cancer progression.
- To elucidate the relationship between PML, androgen receptor (AR) transactivation, and p53 activity in prostate cancer cells.
Main Methods:
- Utilized CWR22R prostate cancer cells to study PML protein expression under androgen influence.
- Assessed the impact of PML on AR transactivation and p53 activity.
- Examined the effect of PML on cell colony formation, including experiments with PML siRNA.
Main Results:
- PML protein expression is suppressed by androgen in CWR22R prostate cancer cells.
- PML selectively suppresses AR transactivation and positively correlates with p21 protein levels.
- PML enhances p53 transcription ability, inhibits CWR22R cell colony formation, while PML siRNA increases AR activity and colony formation.
Conclusions:
- PML functions as a tumor suppressor in prostate cancer.
- PML inhibits prostate cancer cell growth by suppressing AR transactivation and/or enhancing p53 activity.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Negative Regulator Molecules

